Inventors with similar research interests:
Location History:
- Wetzlar, DE (2000)
- Ingelheim am Rhein, DE (2013)
- Biberach, DE (2003 - 2015)
- Biberach an der Riss, DE (2014 - 2024)
Company Filing History:
93 out of 1,535 
11 out of 194 
7 out of 85 
Years Active: 2000-2025
Title: Matthias Eckhardt: A Pioneering Innovator in Pharmaceutical Research
Introduction:
Matthias Eckhardt, a distinguished inventor based in Biberach, Germany, has made significant contributions to the field of pharmaceutical research. With an impressive portfolio of 106 patents and a remarkable career history, Eckhardt's expertise lies in developing novel treatment methods for diseases by harnessing the potential of plasma kallikrein inhibitors and platelet activating factor receptor antagonists. This article delves into his latest patents, career highlights, collaborations, and overall contributions to the field.
Latest Patents:
One of Eckhardt's recent patents focuses on the development of heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors. These compounds, represented by the formula (I), have demonstrated potential in the treatment of various diseases influenced by plasma kallikrein inhibition. The patent also covers the usage methods of the compounds for therapeutic purposes.
Another noteworthy patent by Eckhardt involves cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists. These compounds, represented by the formula (I.0), have shown promise in treating diseases that can be influenced by blocking the activity mediated by the platelet activating factor receptor. The patent highlights the practical applications of these compounds and their pharmaceutically acceptable salts.
Career Highlights:
Matthias Eckhardt has an extensive career history, with notable contributions made during his tenure at renowned companies in the pharmaceutical industry. He has played a significant role in the research and development efforts at Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG – leading pharmaceutical companies known for their ground-breaking advancements in medicine. Eckhardt's innovative ideas and visionary thinking have undoubtedly contributed to the success of these organizations.
Collaborations:
Throughout his career, Eckhardt has had the opportunity to collaborate with esteemed colleagues in the field. Two notable coworkers that he has worked closely with are Frank Himmelsbach and Elke Langkopf. Such collaborations are essential in pushing the boundaries of knowledge and fostering a collaborative environment, which leads to breakthrough inventions and advancements in the pharmaceutical industry.
Conclusion:
Matthias Eckhardt's extensive patent portfolio, including his recent patents involving plasma kallikrein inhibitors and platelet activating factor receptor antagonists, exemplify his significant contributions to the field of pharmaceutical research. His work at industry-leading companies, such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG, further highlights his expertise and innovative thinking. Eckhardt's collaborations with esteemed colleagues have undoubtedly played a crucial role in advancing the understanding and treatment of diseases. As a pioneering innovator, his contributions continue to shape the landscape of pharmaceutical research, bringing us closer to novel therapeutic interventions that have the potential to improve countless lives.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.